Clinical and methylomic features of spinal meningiomas-Reference-Cited by-同舟云学术

Clinical and methylomic features of spinal meningiomas

Published:2024-09-10 Issue: Volume: Page:
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Nandoliya Khizar R.,Congivaram Harrshavasan,Youngblood Mark W.,Chen William C.,Chaliparambil Rahul K.,Horbinski Craig M.,Choudhury Abrar,Brat Daniel J.,Chandler James P.,Magill Stephen T.,Wolinsky Jean-Paul

Funder

Neurosurgery Research and Education Foundation

Malnati Brain Brain Tumor Institute of Northwestern University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11060-024-04736-w.pdf

Reference39 articles.

1. Ostrom QT, Price M, Neff C et al (2023) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2016–2020. Neurooncology 25(Supplement4):iv1–iv99. https://doi.org/10.1093/neuonc/noad149

2. Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol Aug 2(8):1231–1251. https://doi.org/10.1093/neuonc/noab106

3. Choudhury A, Magill ST, Eaton CD et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet May 54(5):649–659. https://doi.org/10.1038/s41588-022-01061-8

4. Choudhury A, Chen WC, Lucas CG et al (2023) Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro Oncol Mar 14(3):520–530. https://doi.org/10.1093/neuonc/noac224

5. Youngblood MW, Miyagishima DF, Jin L et al (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol May 5(5):783–794. https://doi.org/10.1093/neuonc/noaa226